Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

Emmy Award nominee to disrupt the silence in second Vice-Chancellor’s lecture
2015-04-24

Philip Miller

The second instalment of the Vice-Chancellor’s Lecture Series is about to take place on the Bloemfontein Campus. The lecture series – launched in March 2015 by Constitutional Court Judge Albie Sachs – forms part of a five-year research project led by Prof Pumla Gobodo-Madikizela and funded by the Mellon Foundation.

Disrupting the Silence: The Past and Transnational Memory

Internationally-acclaimed composer and sound artist, Philip Miller, will deliver the next lecture in this series on Wednesday 29 April 2015. Miller is currently an honorary fellow at APC (Archive and Public Culture) at the University of Cape Town. His discussion will centre on the topic of ‘Disrupting the Silence: The Past and Transnational Memory’. This will expand on the research project’s overarching theme of Trauma, Memory and Representations of the Past.

The details of the event are:
Date: 29 April 2015
Time: 12:30
Venue: Albert Wessels Auditorium, Bloemfontein Campus
RSVP: Jo-Anne Naidoo at NaidooJA@ufs.ac.za

Compositions and productions

In one of his compositions, ‘REwind: A Cantata for Voice, Tape and Testimony’ Miller incorporates actual testimonies recorded during the Truth and Reconciliation Commission (TRC) hearings. Through combining the audio of these testimonies with vocal soloists, chorus, a string octet and powerful projected images, the boundaries between victims, perpetrators and listeners blur.

Miller has been nominated for an Emmy Award in 2013 for his soundtrack to HBO’s film ‘The Girl’. Miller’s other works include the soundtrack for the film ‘Black Butterflies’, which won him best film score at the South African Film and Television Awards in 2012. He also composed the film score for the ‘Bang Bang Club’, which was nominated for a Genie Award in Canada, as well as for Rehad Desai’s Marikana investigation, ‘Miners Shot Down’.

He also has a long-standing collaboration with internationally-renown visual artist William Kentridge. Their most recent collaboration is the five-screen multimedia installation with a moving sculpture and immersive soundscape ‘The Refusal of Time’. His latest work, ‘Extracts from the Underground’, explores the subterranean sound world of miners in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept